rs117465420

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020877.5(DNAH2):​c.12303A>T​(p.Leu4101Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0235 in 1,614,068 control chromosomes in the GnomAD database, including 618 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 62 hom., cov: 32)
Exomes 𝑓: 0.024 ( 556 hom. )

Consequence

DNAH2
NM_020877.5 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 4.05

Publications

11 publications found
Variant links:
Genes affected
DNAH2 (HGNC:2948): (dynein axonemal heavy chain 2) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH2 is an axonemal inner arm dynein heavy chain (Chapelin et al., 1997 [PubMed 9256245]).[supplied by OMIM, Mar 2008]
DNAH2 Gene-Disease associations (from GenCC):
  • spermatogenic failure 45
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041172802).
BP6
Variant 17-7831158-A-T is Benign according to our data. Variant chr17-7831158-A-T is described in ClinVar as Benign. ClinVar VariationId is 402715.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0786 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH2NM_020877.5 linkc.12303A>T p.Leu4101Phe missense_variant Exon 80 of 86 ENST00000572933.6 NP_065928.2 Q9P225-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH2ENST00000572933.6 linkc.12303A>T p.Leu4101Phe missense_variant Exon 80 of 86 2 NM_020877.5 ENSP00000458355.1 Q9P225-1
DNAH2ENST00000389173.6 linkc.12303A>T p.Leu4101Phe missense_variant Exon 79 of 85 2 ENSP00000373825.2 Q9P225-1
DNAH2ENST00000575105.1 linkc.3150A>T p.Leu1050Phe missense_variant Exon 21 of 23 5 ENSP00000461726.1 I3L520

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3513
AN:
152102
Hom.:
62
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00727
Gnomad AMI
AF:
0.0406
Gnomad AMR
AF:
0.0347
Gnomad ASJ
AF:
0.0591
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.00705
Gnomad FIN
AF:
0.0514
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.0255
Gnomad OTH
AF:
0.0440
GnomAD2 exomes
AF:
0.0245
AC:
6161
AN:
251444
AF XY:
0.0247
show subpopulations
Gnomad AFR exome
AF:
0.00634
Gnomad AMR exome
AF:
0.0201
Gnomad ASJ exome
AF:
0.0602
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0505
Gnomad NFE exome
AF:
0.0279
Gnomad OTH exome
AF:
0.0386
GnomAD4 exome
AF:
0.0235
AC:
34421
AN:
1461848
Hom.:
556
Cov.:
32
AF XY:
0.0235
AC XY:
17121
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00541
AC:
181
AN:
33480
American (AMR)
AF:
0.0221
AC:
990
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0568
AC:
1484
AN:
26134
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39700
South Asian (SAS)
AF:
0.00883
AC:
762
AN:
86258
European-Finnish (FIN)
AF:
0.0496
AC:
2647
AN:
53380
Middle Eastern (MID)
AF:
0.0848
AC:
489
AN:
5768
European-Non Finnish (NFE)
AF:
0.0235
AC:
26093
AN:
1112010
Other (OTH)
AF:
0.0293
AC:
1768
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2227
4454
6682
8909
11136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3514
AN:
152220
Hom.:
62
Cov.:
32
AF XY:
0.0244
AC XY:
1815
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00727
AC:
302
AN:
41528
American (AMR)
AF:
0.0346
AC:
530
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0591
AC:
205
AN:
3468
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5184
South Asian (SAS)
AF:
0.00684
AC:
33
AN:
4822
European-Finnish (FIN)
AF:
0.0514
AC:
544
AN:
10590
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.0255
AC:
1733
AN:
68000
Other (OTH)
AF:
0.0436
AC:
92
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
179
359
538
718
897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0285
Hom.:
30
Bravo
AF:
0.0212
TwinsUK
AF:
0.0218
AC:
81
ALSPAC
AF:
0.0254
AC:
98
ESP6500AA
AF:
0.00658
AC:
29
ESP6500EA
AF:
0.0295
AC:
254
ExAC
AF:
0.0232
AC:
2816
Asia WGS
AF:
0.00751
AC:
26
AN:
3478
EpiCase
AF:
0.0345
EpiControl
AF:
0.0338

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

DNAH2-related disorder Benign:1
May 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T;T;.
Eigen
Benign
0.090
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.85
.;T;T
MetaRNN
Benign
0.0041
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M;M;.
PhyloP100
4.0
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.7
.;N;.
REVEL
Benign
0.083
Sift
Benign
0.050
.;D;.
Sift4G
Uncertain
0.055
.;.;T
Polyphen
0.41
B;B;.
Vest4
0.097
MutPred
0.34
Loss of ubiquitination at K4096 (P = 0.0992);Loss of ubiquitination at K4096 (P = 0.0992);.;
MPC
0.50
ClinPred
0.019
T
GERP RS
3.6
Varity_R
0.40
gMVP
0.14
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117465420; hg19: chr17-7734476; COSMIC: COSV66728303; API